Literature DB >> 25779224

Modulation of tumor cell migration, invasion and cell-matrix adhesion by human monopolar spindle-one-binder 2.

Wenjuan Wu1, Xizhi Zhang2, Haonan Qin1, Wanxin Peng3, Qingyu Xue4, Houning Lv1, Hua Zhang1, Yumei Qiu1, Haichao Cheng1, Yu Zhang1, Zhiyong Yu4, Weigan Shen1.   

Abstract

Human monopolar spindle-one-binder 2 (hMOB2) is a member of the hMOB family of proteins, and it has been reported to regulate the nuclear-Dbf2-related kinase (NDR) activation. However, the function of hMOB2 expression in tumor cell adhesion and motility has not been addressed. Herein, the lentiviral-mediated overexpression and the knockdown of hMOB2 in HepG2 and SMMC-7721 cells was established. It was demonstrated that overexpression of hMOB2 significantly reduced the cell motility and enhanced the cell-matrix adhesion, while the hMOB2 knockdown decreased not only the cell motility, but also the cell-matrix adhesion. Immunofluorescence results showed that both hMOB2 overexpression and knockdown altered assembly of the focal adhesions and the actin cytoskeleton rearrangement. Furthermore, the focal adhesion kinase (FAK)-Src-paxillin signal pathway activated by hMOB2 was confirmed to be involved in controlling the cell motility and the cell-matrix adhesion. These results demonstrated that the altered cell-matrix adhesion and cell motility induced by hMOB2 expression was caused by the assembly of focal adhesions as well as the actin cytoskeleton rearrangement through the activation of the FAK-Src-paxillin signal pathway, unveiling a novel mechanism of cell motility and cell-matrix adhesion regulation induced by hMOB2 expression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25779224     DOI: 10.3892/or.2015.3855

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  3 in total

1.  Monopolar spindle-one-binder protein 2 regulates the activity of large tumor suppressor/yes-associated protein to inhibit the motility of SMMC-7721 hepatocellular carcinoma cells.

Authors:  Weicheng Zhang; Jingyuan Shen; Fengming Gu; Ying Zhang; Wenjuan Wu; Jiachun Weng; Yuexia Liao; Zijing Deng; Qing Yuan; Lu Zheng; Yu Zhang; Weigan Shen
Journal:  Oncol Lett       Date:  2018-02-05       Impact factor: 2.967

2.  Silencing of TAZ inhibits the motility of hepatocellular carcinoma cells through autophagy induction.

Authors:  Wei Zhou; Jiachun Weng; Keyan Wu; Xiao Xu; Hui Wang; Jing Zhang; Chengxue Zhao; Jie Yang; Yu Zhang; Weigan Shen
Journal:  Cancer Manag Res       Date:  2019-09-26       Impact factor: 3.989

3.  4E-BP1Thr46 Phosphorylation Association with Poor Prognosis in Quantitative Phosphoproteomics of Portal Vein Tumor Thrombus Revealed that 4E-BP1Thr46 Phosphorylation is Associated with Poor Prognosis in HCC.

Authors:  Xincong Lin; Yao Huang; Ying Sun; Xionghong Tan; Jiahe Ouyang; Bixing Zhao; Yingchao Wang; Xiaohua Xing; Jingfeng Liu
Journal:  Cancer Manag Res       Date:  2020-01-07       Impact factor: 3.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.